BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34607185)

  • 1. Neurobiology of cataplexy.
    Seifinejad A; Vassalli A; Tafti M
    Sleep Med Rev; 2021 Dec; 60():101546. PubMed ID: 34607185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of orexinergic system in the regulation of cataplexy.
    Koyama Y
    Peptides; 2023 Nov; 169():171080. PubMed ID: 37598758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
    Dauvilliers Y; Jennum P; Plazzi G
    Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of orexin signaling during sleep is involved in abnormal REM sleep architecture in narcolepsy.
    Ito H; Fukatsu N; Rahaman SM; Mukai Y; Izawa S; Ono D; Kilduff TS; Yamanaka A
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2301951120. PubMed ID: 37796986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretinergic interactions with the serotonergic system regulate REM sleep and cataplexy.
    Seifinejad A; Li S; Possovre ML; Vassalli A; Tafti M
    Nat Commun; 2020 Nov; 11(1):6034. PubMed ID: 33247179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder.
    Luppi PH; Clément O; Sapin E; Gervasoni D; Peyron C; Léger L; Salvert D; Fort P
    Sleep Med Rev; 2011 Jun; 15(3):153-63. PubMed ID: 21115377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy.
    Naganuma F; Bandaru SS; Absi G; Mahoney CE; Scammell TE; Vetrivelan R
    Neurobiol Dis; 2018 Dec; 120():12-20. PubMed ID: 30149182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Discrete Glycinergic Neuronal Population in the Ventromedial Medulla That Induces Muscle Atonia during REM Sleep and Cataplexy in Mice.
    Uchida S; Soya S; Saito YC; Hirano A; Koga K; Tsuda M; Abe M; Sakimura K; Sakurai T
    J Neurosci; 2021 Feb; 41(7):1582-1596. PubMed ID: 33372061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A circuit perspective on narcolepsy.
    Adamantidis AR; Schmidt MH; Carter ME; Burdakov D; Peyron C; Scammell TE
    Sleep; 2020 May; 43(5):. PubMed ID: 31919524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.
    Kaur S; Thankachan S; Begum S; Liu M; Blanco-Centurion C; Shiromani PJ
    PLoS One; 2009 Jul; 4(7):e6346. PubMed ID: 19623260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.
    Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS
    Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
    Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
    Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural Control of REM Sleep and Motor Atonia: Current Perspectives.
    Vetrivelan R; Bandaru SS
    Curr Neurol Neurosci Rep; 2023 Dec; 23(12):907-923. PubMed ID: 38060134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of pontine neurons during sleep and cataplexy in hypocretin knock-out mice.
    Thankachan S; Kaur S; Shiromani PJ
    J Neurosci; 2009 Feb; 29(5):1580-5. PubMed ID: 19193905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep, sleep disorders and hypocretin (orexin).
    Mignot E
    Sleep Med; 2004 Jun; 5 Suppl 1():S2-8. PubMed ID: 15301991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
    Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
    Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-related differences within sleep-wake dynamics, cataplexy, and EEG fast-delta power in a narcolepsy mouse model.
    Piilgaard L; Rose L; Gylling Hviid C; Kohlmeier KA; Kornum BR
    Sleep; 2022 Jul; 45(7):. PubMed ID: 35266540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep transitions in hypocretin-deficient narcolepsy.
    Sorensen GL; Knudsen S; Jennum P
    Sleep; 2013 Aug; 36(8):1173-7. PubMed ID: 23904677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.